Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$59.46
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | MRK Avg Daily Volume: 11,372,400
Last Update: 05/27/15 - 4:00 PM EDT
Volume: 0
YTD Performance: 4.70%
Open: $0.00
Previous Close: $59.46
52 Week Range: $52.49 - $63.62
Oustanding Shares: 2,825,221,749
Market Cap: 166,603,326,539
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 6 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.08 2.08 2.08
Latest Dividend: 0.45
Latest Dividend Yield: 3.05%
Dividend Ex-Date: 06/11/15
Price Earnings Ratio: 15.40
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
15.40 15.40 26.72
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.57% 4.89% 58.35%
GROWTH 12 Mo 3 Yr CAGR
Revenue -4.10 -0.12 -0.04
Net Income 164.20 0.87 0.23
EPS 176.90 1.02 0.26
Earnings for MRK:
EBITDA 13.37B
Revenue 42.24B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.79 $0.90 $3.43 $3.81
Number of Analysts 8 7 12 11
High Estimate $0.84 $0.93 $3.47 $3.97
Low Estimate $0.74 $0.86 $3.36 $3.56
Prior Year $0.85 $0.90 $3.49 $3.43
Growth Rate (Year over Year) -6.91% 0.16% -1.62% 10.89%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Have it ready in case market turns volatile.
With a weak dollar, calm oil and tame rates, we're doing fine.
Remember that rotations are vicious.
Bullish
May 04, 2015 | 8:09 AM EDT
Shares of MRK now seen reaching $65, according to BMO Capital. Estimates also upped, as the Januvia upgrade has been removed and the pi...
And many won't hold up on appeal.
The Fed's meeting starts; earnings keep coming.
Apple is higher after-hours on better-than-expected results.

Columnist Conversations

Market recovers from yesterday's losses as investors go back into "risk on" mode. Concert Pharmaceuticals (CNC...
We added this name a few weeks back and now it is the talk of the buyout craze. No matter, because like CRM w...
Intel (INTC)'s pattern off the March corrective low (29.31) exhibits bullish form, which "warns us" that INTC ...
Thanks brotha appreciate the love! Keep an eye on $YUM -- funny feeling the Street could get behind the name a...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.